BACKGROUND High systolic blood pressure (SBP) increases cardiac afterload, whereas low diastolic blood pressure (DBP) may lead to impaired coronary perfusion. Thus, wide pulse pressure (high systolic, low diastolic [HSLD]) may contribute to myocardial ischemia and also be a predictor of adverse cardiovascular events.
H ypertension is a well-established and powerful risk factor for cardiovascular disease (1) (2) (3) (4) . Accordingly, treatment of hypertension is a priority in the management of coronary artery disease (CAD) (5, 6) . Historically, the emphasis has been on targeting systolic blood pressure (SBP), as there was a presumed positive linear correlation between increasing SBP and risk of adverse cardiovascular outcomes (7) (8) (9) . The recent SPRINT (Systolic Blood Pressure Intervention Trial) study provided compelling support for aggressive treatment of SBP (10) in high-risk nondiabetic patients, demonstrating more favorable outcomes with a target SBP <120 mm Hg.
However, it has become increasingly well recognized that aggressively lowering diastolic blood pressure (DBP) can lead to a paradoxical increase in adverse outcomes, particularly in the presence of CAD (11) (12) (13) . A subanalysis of the Framingham study (14) demonstrated a J-curve between DBP and risk of adverse cardiac events, with an increased risk of adverse events either side of target range, and subsequent studies have confirmed that this effect appears to be independent of pharmacotherapy and structural function (14) (15) (16) (17) .
Coronary perfusion occurs predominantly during cardiac diastole; therefore, aggressive reduction of DBP may compromise cardiac perfusion and worsen ischemia in patients with CAD (17, 18) . The detrimental impact of systolic hypertension on cardiac function and cardiovascular risk has been well described, and elevated SBP also increases afterload and myocardial energy requirements (19) . As such, the combination of a high SBP and low DBP, that is, a wide pulse pressure, may amplify the individual detrimental effects of systolic hypertension and diastolic hypotension. Pulse pressure, the calculated difference between SBP and DBP, reflects cardiac contractility and arterial stiffness (20) . Elevated pulse pressure is associated with an increased risk of adverse cardiac events (21, 22) and has been found to be a superior independent predictor of risk than its individual components (23, 24) .
In this context, we aimed to examine the effect of pre-procedural blood pressure (BP) on outcomes in the setting of percutaneous coronary intervention (PCI), with the hypothesis that a wide pulse pressure may predict poor outcomes following PCI.
METHODS
We reviewed 10,876 consecutive PCI procedures from August 2009 to December 2016 with a pre-procedural BP recorded. The patients were prospectively enrolled in the Melbourne Interventional Group (MIG) registry.
The MIG registry, which has been previously described in detail (25) , is a collaboration of interven- (27) . At the most recent audit, data accuracy was 98%, which compares favorably to other large registries (28) . Approval was gained from each individual hospital's ethics committee prior to commencement of the registry. "Opt-out" informed consent was obtained in all patients (26 Values are n (%) or mean AE SD.
NSTEMI ¼ non-ST-segment elevation myocardial infarction; NYHA ¼ New York Heart Association; other abbreviations as in Table 1 . Table 3) .
OUTCOMES. Outcomes at 30 days are summarized in Table 4 . There was no significant difference between rates of mortality (including cardiac death), MI, TVR, MACE, or stroke between blood pressure groups.
Blood pressure was not an independent predictor of MACE at 30 days on multivariate analysis.
Antihypertensive use at 30 days is summarized in Table 6 .
Long-term mortality data were available for 5,818
patients, and Kaplan-Meier estimates for survival are shown in Figure 1 . 
DISCUSSION
Our study has demonstrated that the combination of high SBP and low DBP (wide pulse pressure) prior to PCI is associated with higher burden of chronic cardiac risk factors, reflecting higher baseline risk and potentially less arterial compliance (Central Illustration). This cohort of patients also had higher long-term mortality and major adverse cardiac outcomes. In contrast, patients with high DBP in combination with low SBP (narrow pulse pressure) had lower long-term mortality, and this was an independent predictor of lower long-term mortality.
Our study is one of the first to examine the influence of pulse pressure in the setting of PCI and provides insight into potential targets for therapy in this context (31, 32) . The cohort with HSLD demonstrated a significantly higher burden of cardiovascular risk factors such as older age, diabetes, previous CAD, and hypercholesterolemia. Age and diabetes have been previously linked to wide pulse pressure and likely reflect older, stiffened pathological arteries (33) .
Chronic age-related hypertension tends to result in an have been demonstrated as independent predictors of adverse outcomes (35) (36) (37) (38) (39) . The detrimental impact of reduced coronary supply in diastolic hypotension appears to be amplified by the increased myocardial requirements in systolic hypertension (19) .
Mortality was significantly higher in patients with Values are n (%) or n. Tables 1 and 4 . 
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Long-term mortality of the cohort according to the combinations of systolic and diastolic blood pressure, including the numbers at risk. It shows that low systolic associated with high diastolic (LSHD) blood pressure predicts lower mortality, whereas high systolic associated with low diastolic (HSLD) blood pressure is associated with worse survival. The analyses of the primary outcomes and other composites of death and adverse cardiovascular events were performed with the use of Kaplan-Meier survival estimates, with the log-rank test for the comparison of groups. HSHD ¼ high systolic high diastolic; LSLD ¼ low systolic low diastolic. independently of pulse pressure, suggesting that the effect is not explained by arterial stiffness alone (40) .
Our study suggests that a narrow pulse pressure independently predicts lower long-term mortality.
Wide pulse pressure has previously been described as a predictor of adverse outcomes in the setting of CAD (4, 14, 22, 33, 41, 42) , and pulse pressure has been demonstrated to be a better predictor than SBP, DBP, and mean arterial pressure (21, 33) . Vaccarino et al. (33) found that a 10-mm Hg increase in pulse pressure
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is associated with a 12% increase in risk of CAD in the elderly, and it was a stronger predictor than both mean arterial pressure and SBP alone (33) .
As coronary perfusion occurs during diastole, a reduction in DBP may impede coronary flow and amplify ischemia, particularly in arteries with preexisting obstruction (41) . The presence of coronary stenoses results in poor flow reserve and renders the myocardium vulnerable to ischemia (43). Coronary perfusion is autoregulated such that a constant perfusion pressure is maintained over a wide range of blood pressures (44) . This intrinsic mechanism is disrupted in the presence of coronary disease, and therefore, a drop in pressure can result in heightened ischemia distal to stenosis (45) . Patients with chronic hypertension operate at a higher perfusion threshold (45) , and a reduction of BP in these patients may result in hypoperfusion and ischemia (44, (46) (47) (48) . In a study examining patients with ambulatory BP and electrocardiographic monitoring, ischemic events were temporally associated with diastolic rather than systolic hypotension (49) .
The ideal blood pressure target prior to PCI is un- (50) suggest that there is a significant increase in adverse events with a SBP below 120 mm Hg, potentially due to poor perfusion leading to an increased risk of ischemic events.
There are little data directly comparing the effects of antihypertensive therapies on pulse pressure and outcomes following PCI. Indeed, there are no agents that target SBP in isolation, which may be the preferential form of treatment in this setting. However, examining the pharmacological action of antihypertensive agents gives insight into potential advantages of various agents (17) . Antihypertensive agents that reduce heart rate, such as centrally acting CCBs and beta-blockers, prolong diastole and therefore potentially extend coronary perfusion time. However, in the absence of heart failure, evidence for the survival benefit of using beta-blockers in the setting of MI is limited (51). In addition, central CCBs also improve arterial compliance through their vasodilatory effects and, therefore, preferentially target systolic blood pressure (52) . Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, as well as CCBs, reduce left ventricular hypertrophy and hypertensive vascular disease more than beta-blockers (53, 54) , making them potentially preferable agents in certain patient groups. Interestingly, the HSLD cohort had the highest use of CCBs 30 days post-PCI, suggesting that their practitioners may have recognized these benefits in this group. Further research is required in this domain.
STUDY LIMITATIONS. Despite the fact that all data in our registry are collected prospectively, our study was limited by its retrospective design, as well as the relatively short-term follow-up. Furthermore, a single pre-procedural blood pressure only provides a snapshot into hemodynamics and may not reflect the patient's usual blood pressure. Indeed, there may be an element of "white-coat" hypertension that we are unable to control for. However, the clear differentiation between our blood pressure cohorts in mortality with long-term follow-up suggests that pre-PCI blood pressure may be a useful prognostic indicator.
CONCLUSIONS
The present study emphasizes the adverse effect of a wide pulse pressure prior to PCI, and has shown that a narrow pulse pressure independently predicts lower long-term mortality. A pre-PCI wide pulse pressure could potentially serve as a marker of risk, in its reflection of chronic disease burden, as well as a potential target for future therapies (55) .
